Literature DB >> 12868122

Role of estrogen and androgen in pubertal skeletal physiology.

Graeme R Frank1.   

Abstract

Since both estrogen and androgen are present in each sex, it has been difficult to discern the exact role that each sex steroid plays in skeletal physiology. However, studying clinical syndromes in which there is either only estrogen or androgen action has allowed us to gain insight into the unique role that each sex steroid plays in the growing skeleton. In complete androgen insensitivity syndrome (AIS) the only functional sex steroid receptor is that for estrogen. Effected XY females have a pubertal growth spurt that is typical of normal females, both in magnitude and timing. Individuals with AIS have a mild reduction in bone density but it is difficult to distinguish whether this is the result of androgen resistance or estrogen deficiency. These observations suggest that estrogen action only is sufficient to induce a normal pubertal growth spurt, epiphyseal maturation, and near normal bone mineral accretion in women. Until recently, the skeletal effects of estrogen were not thought to be of importance in the male. Conventional wisdom dictated that, in the male, testosterone mediated these skeletal changes. The notion that estrogen is of little importance in the male has been challenged by the recent discovery of two human syndromes in which estrogen action is lacking. In males with either estrogen resistance (inability to respond to circulating estrogen) or aromatase deficiency (inability to synthesize estradiol), as a result of the lack of estrogen action, a pubertal growth spurt does not appear to occur. Furthermore, complete epiphyseal maturation does not take place allowing for continued growth in adulthood and resultant tall stature. Finally normal bone mineral accretion does not take place resulting in severe osteoporosis. These findings indicate that estrogen plays a critical role in skeletal physiology of males as well as females. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12868122     DOI: 10.1002/mpo.10340

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  23 in total

Review 1.  The ins and outs of GPR30: a transmembrane estrogen receptor.

Authors:  Eric R Prossnitz; Tudor I Oprea; Larry A Sklar; Jeffrey B Arterburn
Journal:  J Steroid Biochem Mol Biol       Date:  2008-03-06       Impact factor: 4.292

2.  Metastasin S100A4 is a mediator of sex hormone-dependent formation of the cortical bone.

Authors:  Malin C Erlandsson; Li Bian; Ing-Marie Jonsson; Karin M Andersson; Maria I Bokarewa
Journal:  Mol Endocrinol       Date:  2013-06-24

3.  SOX9 keeps growth plates and articular cartilage healthy by inhibiting chondrocyte dedifferentiation/osteoblastic redifferentiation.

Authors:  Abdul Haseeb; Ranjan Kc; Marco Angelozzi; Charles de Charleroy; Danielle Rux; Robert J Tower; Lutian Yao; Renata Pellegrino da Silva; Maurizio Pacifici; Ling Qin; Véronique Lefebvre
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-23       Impact factor: 11.205

4.  Bone density in post-pubertal adolescent survivors of childhood brain tumors.

Authors:  Laurie E Cohen; Joshua H Gordon; Erica Y Popovsky; Nina N Sainath; Henry A Feldman; Mark W Kieran; Catherine M Gordon
Journal:  Pediatr Blood Cancer       Date:  2011-08-29       Impact factor: 3.167

5.  GPR30 FORMS AN INTEGRAL PART OF E2-PROTECTIVE PATHWAY IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS.

Authors:  Sheetal Bodhankar; Halina Offner
Journal:  Immunol Endocr Metab Agents Med Chem       Date:  2011-12

Review 6.  The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice.

Authors:  Lisa E Olson; Claes Ohlsson; Subburaman Mohan
Journal:  Calcif Tissue Int       Date:  2010-11-27       Impact factor: 4.333

7.  Early Maturity as the New Normal: A Century-long Study of Bone Age.

Authors:  Melanie E Boeyer; Richard J Sherwood; Chelsea B Deroche; Dana L Duren
Journal:  Clin Orthop Relat Res       Date:  2018-11       Impact factor: 4.176

8.  Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene.

Authors:  D L S Danilovic; P H S Correa; E M F Costa; K F S Melo; B B Mendonca; I J P Arnhold
Journal:  Osteoporos Int       Date:  2006-11-01       Impact factor: 4.507

9.  Inactivation of the androgen receptor in bone-forming cells leads to trabecular bone loss in adult female mice.

Authors:  Jorma A Määttä; Kalman G Büki; Kaisa K Ivaska; Vappu Nieminen-Pihala; Teresa D Elo; Tiina Kähkönen; Matti Poutanen; Pirkko Härkönen; Kalervo Väänänen
Journal:  Bonekey Rep       Date:  2013-11-06

10.  Vitamin D status and parathyroid hormone relationship in adolescents and its association with bone health parameters: analysis of the Northern Ireland Young Heart's Project.

Authors:  T R Hill; A A Cotter; S Mitchell; C A Boreham; W Dubitzky; L Murray; J J Strain; A Flynn; P J Robson; J M W Wallace; M Kiely; K D Cashman
Journal:  Osteoporos Int       Date:  2009-05-13       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.